Get started
Author

Kathleen I. Pishas

Observed names: K I Pishas, KATHLEEN I. PISHAS, Kathleen I. Pishas, Kathleen I Pishas, Kathleen Pishas, Pishas, Kathleen I, Pishas, Kathleen I.
Observed institutions: South Australia Pathology, Nationwide Children's Hospital, Royal Adelaide Hospital, The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Basil Hetzel Institute, Queen Elizabeth Hospital, Queen Elizabeth Hospital, Queen Elizabeth Hospital, Hanson Institute, Abigail Wexner Research Institute, The University of Adelaide
ORCID: 0000-0001-7863-807X
Observed ORCID: 0000-0001-7863-807X
OpenAlex ID: A5077917060
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
2023 · Nikki L. Burdett, Madelynne O. Willis, et al. · Nature Genetics · 84
Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
2010 · Kathleen I. Pishas, Fares Al-Ejeh, et al. · Clinical Cancer Research · 71
PDF
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
2016 · Emily R. Theisen, Kathleen I. Pishas, et al. · Oncotarget · 70
PDF
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
2018 · Kathleen I. Pishas, Christina D. Drenberg, et al. · Molecular Cancer Therapeutics · 60
Recent advances in targeted therapy for Ewing sarcoma
2016 · Kathleen I. Pishas, Stephen L. Lessnick · F1000Research · 50
PDF
Targeting the p53 Pathway in Ewing Sarcoma
2010 · Paul M. Neilsen, Kathleen I. Pishas, et al. · Sarcoma · 42
PDF
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer
2017 · R Shakya, G A Tarulli, et al. · Oncogene · 40
Identification of vitamin D3 target genes in human breast cancer tissue
2015 · Lei Sheng, Paul H. Anderson, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 36
Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein
2020 · Emily R. Theisen, Julia Selich-Anderson, et al. · Epigenetics · 33
PDF
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
2022 · Dane Cheasley, Marta Llaurado Fernandez, et al. · npj Precision Oncology · 28
PDF
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
2020 · Iftekhar A. Showpnil, Kyle R. Miller, et al. · Journal of Visualized Experiments · 28
PDF
Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis
2019 · Emily R. Theisen, Kyle R. Miller, et al. · Genes & Cancer · 25
PDF
Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling
2013 · Kathleen I. Pishas, Susan J. Neuhaus, et al. · Cancer Research · 24
PDF
XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
2015 · Kathleen I. Pishas, Alaknanda Adwal, et al. · Scientific Reports · 22
PDF
New 26S Proteasome Inhibitors with High Selectivity for Chymotrypsin-Like Activity and p53-Dependent Cytotoxicity
2012 · Paul M. Neilsen, Ashok D. Pehere, et al. · ACS Chemical Biology · 21
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues
2012 · Rachel J. Suetani, Kristen Ho, et al. · Molecular and Cellular Endocrinology · 16
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
2024 · Kathleen I. Pishas, Karla J. Cowley, et al. · Scientific Data · 15
PDF
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
2024 · Flurina A.M. Saner, Kazuaki Takahashi, et al. · Clinical Cancer Research · 15
PDF
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
2021 · Davis T. Weaver, Kathleen I. Pishas, et al. · PLoS Computational Biology · 15
PDF
Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma
2022 · E. John Tokarsky, Jesse C. Crow, et al. · Molecular Cancer Research · 14
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
2018 · Kathleen I. Pishas, Stephen L. Lessnick · Oncotarget · 13
PDF
Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
2023 · Flurina A. M. Saner, Kazuaki Takahashi, et al. · medRxiv · 6
PDF
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non‐carriers: results from a rapid autopsy programme
2023 · Heather Thorne, Lisa Devereux, et al. · Histopathology · 6
PDF
Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
2021 · Kathleen I. Pishas, Karla J. Cowley, et al. · Cancers · 6
PDF
Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
2019 · Priyal O. Patel, Kathleen I. Pishas, et al. · Oncotarget · 5
Works count: 161
Citation count: 755
H-index: 16
I10-index: 21
Year
Topic
Type